«The Eurasian Congress of Internal Medicine»

Programme

The full version of the program is provided in the Russian version of the website: https://xconf.euat.ru
Please find below the sessions held in English.

09:40-12:00

Plenary session

Biotechnological platforms in diagnostics and treatment. Classics and innovations
Kudlay D.
Novel nicotine delivery systems – a pulmonologist's view
Aisanov Z.
Management of CHF patients: the Republic of Kazakhstan’ experience
Bekbosynova M.
Chronic viral hepatitis B – are treatment options available?
Nikitin I.
New risk factor management paradigms
Arutyunov G.
HFpEF – long-awaited moment of change in therapy
Fomin I.

11:30-12:50

Special Session «Do we know everything about CHF? Resolved and unresolved issues»

Do we have any progress in the diagnosis of CHF?
Ageev F.
Current image of a patient with CHF
Vinogradova N.
Acute decompensation of CHF in patients with impaired carbohydrate metabolism
Koziolova N.
Infections with CHF with low PV: what do we know today?
Arutyunov A.
Treatment of CHF from low to preserved PV – do we have a breakthrough in improving the prognosis of life?
Lopatin Yu.
On the issue of organization of medical care for patients with CHF
Fomin I.

12:50-13:30

Panel discussion of relevant topics

11:30-12:20

Speed Session «Lost chronicles: Problems in diagnosis and treatment of patients with chronic diseases»

New risk groups to look for CHF and CKD
Arutyunov A.
Diagnosing patients with CHF – a hidden threat or a decisive battle
Mareev Yu.
New era in CKD treatment – a long-awaited reality in terms of new discoveries
Bobkova I.
Dapagliflozin in the treatment of patients with CHF – light at the end of the tunnel
Petar Seferovic
Augmented reality: a full spectrum discovery in the treatment of patients with CHF
Vladimir Miloradovic
Unraveled chronicles: accumulated data on the safety of iSGLT-2 use
Petunina N.
Risks of AKI in hospitalized patients with CHF
Fomin I.

12:20-13:00

Panel discussion of relevant topics

13:00-14:30

Break

14:30-16:00

Symposium «Clinical aspects of managing patients with carbohydrate metabolism disorders»

Chairman:
Galstyan G.

Lower extremity lesion in diabetes mellitus
Galstyan G.
Beta-blockers for diabetes: avoiding or saving lives?
Starostina E.
Diabetes mellitus and pregnancy: what a therapist needs to know
Shestakova T.
Effects of SGLT2 inhibitors on renal function in patients with diabetes mellitus
Ivana Bozic Antic

16:00-16:30

Break

16:30-18:00

Symposium «Targeting the heart of diabetes»

Chairman:
Goran Cvijovic

Diastolic heart failure: challenges of diagnosis and treatment
Ana Djordjevic-Dikic
SGLT-2 inhibitors in HFpEF. What to expect?
Vojislav Giga
Cardiovascular benefits of SGLT-2 inhibitors in diabetes patients: A true gift for your Sweetheart!
Marko Stojanovic
Cardiovascular effects of glp-1 ra therapy in diabetic patients
Goran Cvijovic